Press Releases

News

Shea’s President Brian Higgins Named to Roswell Park Board of Directors

Former congressman joins Roswell Park's Board of Directors

Tuesday, December 16, 2025 - 09:00 am

News

Registration opens for 6th Annual IceCycle to end cancer

BUFFALO, N.Y.

Tuesday, December 16, 2025 - 10:27 am

Scientists in white coats and protective gear work in lab

News

Roswell Park Study Shows IL-36 Gamma ‘Armored’ CAR T Cells Can Eradicate Solid Tumors

Findings from the recent study show that 'armored' CAR T cells can eradicate solid tumors

Thursday, December 11, 2025 - 01:00 pm

News

Race, Ethnicity and Donor Type Continue to Affect Survival After Donor Stem Cell Transplant

Roswell Park doctors to present study on disparities in stem cell transplant outcomes

Monday, December 8, 2025 - 02:45 pm

News

Researchers Identify Strategy for Reducing Risk of Acute Graft-Versus-Host Disease for Many With Blood Cancers

A Roswell Park and the University of Minnesota study suggests blocking metabolic pathway may help reduce serious side effects in cancer patients who receive stem cell transplants

Monday, December 8, 2025 - 12:00 pm

News

Roswell Park Leukemia Expert Led ASH 2025 Studies Assessing 2 New Treatment Strategies for Advanced AML

Chief of Leukemia at Roswell Park to present studies on crenolanib and ziftomenib at the American Society of Hematology annual meeting.

Monday, December 8, 2025 - 10:30 am

News

Roswell Park Experts Share Cutting-Edge Breast Cancer Studies at SABCS 2025

More than a dozen Roswell Park teams will showcase new research at the 2025 San Antonio Breast Cancer Symposium this week, highlighting precision-medicine tools and insights that are shaping the future of breast cancer management.

Sunday, December 7, 2025 - 09:00 am

News

Attendees at ASH 2025 Hear Strategy for Improving Efficacy and Reducing Toxicity of CAR T-Cell Therapy

Roswell Park doctors to lead presentation on factors that lead to resistance in CAR T-cell therapy

Sunday, December 7, 2025 - 12:00 pm

doctor in a lab coat stands in a laboratory

News

Roswell Park-Led Clinical Trial Paves Way for FDA Approval of Targeted Drug for Aggressive Leukemia

U.S. FDA approves new drug application for ziftomenib following international study co-led by Roswell Park's Dr. Eunice Wang.

Tuesday, December 2, 2025 - 09:00 am